{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:24:45Z","timestamp":1790886285082,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.atherosclerosis.2021.03.014","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T12:01:11Z","timestamp":1616846471000},"page":"91-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Triglyceride-induced cardiac lipotoxicity is mitigated by Silybum marianum"],"prefix":"10.1016","volume":"324","author":[{"given":"Gemma","family":"Vilahur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4380-0900","authenticated-orcid":false,"given":"Pablo","family":"Sutelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiomar","family":"Mendieta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5572-5883","authenticated-orcid":false,"given":"Soumaya","family":"Ben-Aicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Borrell-Pages","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1995-8249","authenticated-orcid":false,"given":"Javier","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Casan\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9162-2459","authenticated-orcid":false,"given":"Lina","family":"Badimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.atherosclerosis.2021.03.014_bib1","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.3390\/molecules25102415","article-title":"Silymarin and derivatives: from biosynthesis to health benefits","volume":"25","author":"Delmas","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib2","first-page":"308","article-title":"\u201cSilymarin\u201d, a promising pharmacological agent for treatment of diseases","volume":"14","author":"Karimi","year":"2011","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2012.09.034","article-title":"Intravenous silibinin monotherapy shows significant antiviral activity in HCV-infected patients in the peri-transplantation period","volume":"58","author":"Mari\u00f1o","year":"2013","journal-title":"J. Hepatol."},{"issue":"13","key":"10.1016\/j.atherosclerosis.2021.03.014_bib4","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1002\/jsfa.9115","article-title":"Effects of silymarin on metabolic syndrome: a review","volume":"98","author":"Vahabzadeh","year":"2018","journal-title":"J. Sci. Food Agric."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2021.03.014_bib5","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3390\/molecules25092009","article-title":"Silymarin and cancer: a dual strategy in both in chemoprevention and chemosensitivity","volume":"25","author":"Delmas","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.03.014_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.bcp.2014.07.018","article-title":"Natural product agonists of peroxisome proliferator-activated receptor gamma (PPAR\u03b3): a review","volume":"92","author":"Wang","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3389\/fphar.2016.00345","article-title":"Silymarin ameliorates metabolic dysfunction associated with diet-induced obesity via activation of farnesyl X receptor","volume":"7","author":"Gu","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2021.03.014_bib8","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/gut.2006.091967","article-title":"A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations","volume":"55","author":"Federico","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib9","article-title":"The gastroprotective potential of silibinin against Helicobacter pylori infection and gastric tumor cells [published online ahead of print, 2020 Jun 27]","author":"Bittencourt","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib10","doi-asserted-by":"crossref","first-page":"111117","DOI":"10.1016\/j.msec.2020.111117","article-title":"Hepatoprotective effects of silymarin coated gold nanoparticles in experimental cholestasis","volume":"115","author":"Clichici","year":"2020","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib11","article-title":"Silybum marianum (milk thistle) improves vancomycin induced nephrotoxicity by downregulating apoptosis [published online ahead of print, 2020 Jul 7]","author":"Malkani","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib12","doi-asserted-by":"crossref","first-page":"118049","DOI":"10.1016\/j.lfs.2020.118049","article-title":"Silymarin sex-dependently improves cognitive functions and alters TNF-\u03b1, BDNF, and glutamate in the hippocampus of mice with mild traumatic brain injury [published online ahead of print, 2020 Jul 4]","volume":"257","author":"Shokouhi","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.fitote.2014.05.016","article-title":"Silymarin and its constituents in cardiac preconditioning","volume":"97","author":"Zholobenko","year":"2014","journal-title":"Fitoterapia"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.03.014_bib14","first-page":"69","article-title":"[Effects of silybin on acute myocardial infarction and reperfusion injury in anesthetized rats]","volume":"13","author":"Chen","year":"1992","journal-title":"Zhongguo Yaoli Xuebao"},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijcard.2018.06.030","article-title":"Silybum marianum provides cardioprotection and limits adverse remodeling post-myocardial infarction by mitigating oxidative stress and reactive fibrosis","volume":"270","author":"Vilahur","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijcard.2018.07.056","article-title":"Reply to the letter by Dr. Ulas to the manuscript entitled: \u201cSilybum marianum provides cardioprotection and limits adverse remodeling post-myocardial infarction by mitigating oxidative stress and reactive fibrosis\u201d","volume":"270","author":"Vilahur","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib18","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.med.53.082901.104057","article-title":"Lipotoxic diseases","volume":"53","author":"Unger","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.atherosclerosis.2012.07.003","article-title":"Infiltrated cardiac lipids impair myofibroblast-induced healing of the myocardial scar post-myocardial infarction","volume":"224","author":"Vilahur","year":"2012","journal-title":"Atherosclerosis"},{"issue":"9729","key":"10.1016\/j.atherosclerosis.2021.03.014_bib20","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S0140-6736(10)60656-3","article-title":"Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis","volume":"375","author":"Jun","year":"2010","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2021.03.014_bib21","doi-asserted-by":"crossref","first-page":"e673","DOI":"10.1161\/CIR.0000000000000709","volume":"140","author":"Skulas-Ray","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.atherosclerosis.2021.03.014_bib23","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1001\/jama.2020.22258","article-title":"Effect of high-dose omega-3 fatty acids vs corn oil on major adverse cardiovascular events in patients at high cardiovascular risk","volume":"324","author":"Nicholls","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamacardio.2017.5205","article-title":"Omega-3 treatment trialists' collaboration. Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77917 individuals","volume":"3","author":"Aung","year":"2018","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.03.014_bib25","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1161\/CIR.0000000000000743","volume":"141","author":"Carson","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2021.03.014_bib26","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/advances\/nmz007","article-title":"Effects of a paleolithic diet on cardiovascular disease risk factors: a systematic review and meta-analysis of randomized controlled trials [published correction appears in adv nutr. 2020 jul 1;11(4):1054]","volume":"10","author":"Ghaedi","year":"2019","journal-title":"Adv Nutr"},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib28","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9343(02)01244-5","article-title":"Milk thistle for the treatment of liver disease: a systematic review and meta-analysis","volume":"113","author":"Jacobs","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib29","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.biopha.2017.02.016","article-title":"Safety and efficacy of a polyherbal formulation for the management of dyslipidemia and hyperglycemia in patients with advanced-stage of type-2 diabetes","volume":"89","author":"Zarvandi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1472-8206.1999.tb00334.x","article-title":"Gastrointestinal absorption of drugs: methods and studies","volume":"13","author":"Barthe","year":"1999","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib32","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.3748\/wjg.v17.i18.2288","article-title":"Silybin and the liver: from basic research to clinical practice","volume":"17","author":"Loguercio","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib33","first-page":"193","article-title":"A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos)","volume":"10","author":"Kidd","year":"2005","journal-title":"Alternative Med. Rev."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.03.014_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1208\/s12249-019-1609-3","article-title":"Cardioprotective efficacy of silymarin liquisolid in isoproterenol prompted myocardial infarction in rats","volume":"21","author":"Sheta","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib35","doi-asserted-by":"crossref","first-page":"6633","DOI":"10.2147\/IJN.S92665","article-title":"Enhanced oral bioavailability of silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivo","volume":"10","author":"Yang","year":"2015","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2021.03.014_bib36","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1124\/jpet.102.044412","article-title":"Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport","volume":"304","author":"Zhang","year":"2003","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2021.03.014_bib37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1124\/dmd.105.006312","article-title":"Effect of milk thistle (Silybum marianum) and black cohosh (Cimicifuga racemosa) supplementation on digoxin pharmacokinetics in humans","volume":"34","author":"Gurley","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib38","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1023\/A:1025044913766","article-title":"Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells","volume":"20","author":"Zhang","year":"2003","journal-title":"Pharm. Res. (N. Y.)"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2021.03.014_bib39","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1124\/dmd.32.6.587","article-title":"Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases","volume":"32","author":"Sridar","year":"2004","journal-title":"Drug Metab. Dispos."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2021.03.014_bib40","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1080\/00498250903060077","article-title":"Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers","volume":"39","author":"Han","year":"2009","journal-title":"Xenobiotica"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2021.03.014_bib41","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","article-title":"Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo","volume":"97","author":"Hoffmeyer","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib42","first-page":"1","article-title":"Silymarin as a flavonoid-type P-glycoprotein inhibitor with impact on the pharmacokinetics of carbamazepine, oxcarbazepine and phenytoin in rats","author":"Ferreira","year":"2019","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib43","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/mrm.21207","article-title":"T1-weighted magnetic resonance imaging shows fatty deposition after myocardial infarction","volume":"57","author":"Goldfarb","year":"2007","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib44","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/0003-4819-144-7-200604040-00011","article-title":"American College of P, the American Physiological S. Adiposity of the heart, revisited","volume":"144","author":"McGavock","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2021.03.014_bib45","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3390\/cells9020451","article-title":"The crosstalk between cardiac lipotoxicity and mitochondrial oxidative stress in the cardiac alterations in diet-induced obesity in rats","volume":"9","author":"Jim\u00e9nez-Gonz\u00e1lez","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib46","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0022-2275(20)32367-1","article-title":"LDL receptor deficiency unmasks altered VLDL triglyceride metabolism in VLDL receptor transgenic and knockout mice","volume":"41","author":"Tacken","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib47","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/cvr\/cvs136","article-title":"Low-density lipoprotein receptor-related protein 1 mediates hypoxia-induced very low density lipoprotein-cholesteryl ester uptake and accumulation in cardiomyocytes","volume":"94","author":"Cal","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00395-016-0585-y","article-title":"LRP5\/canonical Wnt signalling and healing of ischemic myocardium","volume":"111","author":"Borrell-Pages","year":"2016","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib49","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/jcmm.12396","article-title":"LRP5 deficiency down-regulates Wnt signalling and promotes aortic lipid infiltration in hypercholesterolaemic mice","volume":"19","author":"Borrell-Pages","year":"2015","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib50","first-page":"1060","article-title":"Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases","volume":"320","author":"Eckel","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib51","doi-asserted-by":"crossref","first-page":"132960","DOI":"10.1155\/2008\/132960","article-title":"Peroxisome proliferator activated receptors and lipoprotein metabolism","volume":"2008","author":"Kersten","year":"2008","journal-title":"PPAR Res."},{"issue":"27","key":"10.1016\/j.atherosclerosis.2021.03.014_bib52","doi-asserted-by":"crossref","first-page":"19493","DOI":"10.1074\/jbc.M703330200","article-title":"CD36 is important for fatty acid and cholesterol uptake by the proximal but not distal intestine","volume":"282","author":"Nassir","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.atherosclerosis.2021.03.014_bib53","doi-asserted-by":"crossref","first-page":"8716\u20108723","DOI":"10.1074\/jbc.M509890200","article-title":"Loss of lipoprotein lipase-derived fatty acids leads to increased cardiac glucose metabolism and heart dysfunction","volume":"281","author":"Augustus","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2021.03.014_bib54","doi-asserted-by":"crossref","first-page":"S86\u2010S90","DOI":"10.1194\/jlr.R800085-JLR200","article-title":"Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways","volume":"50","author":"Goldberg","year":"2009","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2021.03.014_bib55","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1592\/phco.29.4.365","article-title":"Influence of intermittent hypoxia on myocardial and hepatic P-glycoprotein expression in a rodent model","volume":"29","author":"Dopp","year":"2009","journal-title":"Pharmacotherapy"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021001222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915021001222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:46:05Z","timestamp":1758156365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915021001222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":55,"alternative-id":["S0021915021001222"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.03.014","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Triglyceride-induced cardiac lipotoxicity is mitigated by Silybum marianum","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2021.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}